In a groundbreaking surgery proceeded a team of doctors at the hospital Georges Pompidou in Paris who implanted for the first time in the world, an autonomous, bioprosthetic
artificial heart, made by the French company Carmat, in a patient suffering from end-stage heart failure. "Implantation unfolded in a satisfactory manner.
The patient is under medical supervision, is awake and conversing with their relatives ", the company announced. In late September, the French authorities had given their approval for this
surgery, giving new hope and perspective to heart patients who are condemned because of the lack of donor organs. "We are pleased that the first
implantation, but obviously it would be premature to draw conclusions after going for a single implant and even the time that has passed since the surgery is very small" commented general manager Marcello Carmat Konviti. Founded by French surgeon Alain Karpentie, who is known worldwide for its cardiac valve Karpentie-Edwards who has invented.
The aim is to cover the shortage of grafts as many people suffering from heart failure at an advanced stage die before a suitable donor is found. "Artificial heart fully mimics the human heart with two ventricles that promote blood in the same way you did and heart muscle, with sensors that allow it to
increase or decrease the rate. When the patient is asleep, the rate drops when going upstairs, increases. Consequently, not related to mechanical pump, "he explained before some months the company cofounder Philip Pouleti. Patient in which the heart was implanted last Wednesday suffering from heart failure at the last stage. The doctors did not give him much room for life and there was no other alternative treatment. Carmat The claims that the artificial heart could save each year tens of thousands of patients, guaranteeing their quality of life unprecedented, without running the risk of organ rejection.
No comments:
Post a Comment